Early Outcomes With HeartWare HVAD as Bridge to Transplant in Children

A Single Institution Experience

Giuseppe Ferro*, Raghav Murthy, Derek Williams, Vinod A. Sebastian, Joseph M. Forbess, Kristine J. Guleserian

*Corresponding author for this work

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The HeartWare HVAD has been used as a bridge to cardiac transplantation in the pediatric population. We describe outcomes following HeartWare HVAD implantation at a single center. A retrospective chart review was performed of all HeartWare HVAD implants performed at our institution between May 2013 and March 2015. Eight children between the ages of 9 and 17 years underwent HVAD implantation as a bridge to transplant (N=7 cardiomyopathy, N=1 complex single ventricle). There was one operative death in the complex single ventricle patient. Seven patients (87%) were successfully bridged to transplant. Median time of support was 24.5 days (range, 6-91 days). All transplanted patients are alive and well at a median follow-up of 448 days. Our results demonstrated that mechanical support with HeartWare HVAD is feasible in patients of varying sizes (from older children to adolescents).

Original languageEnglish (US)
Pages (from-to)85-89
Number of pages5
JournalArtificial Organs
Volume40
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Transplants
Pediatrics
Heart Transplantation
Cardiomyopathies
Population

Keywords

  • Cardiac transplantation
  • Heart failure
  • Pediatric
  • Ventricular assist device

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Biomaterials
  • Biomedical Engineering

Cite this

Ferro, Giuseppe ; Murthy, Raghav ; Williams, Derek ; Sebastian, Vinod A. ; Forbess, Joseph M. ; Guleserian, Kristine J. / Early Outcomes With HeartWare HVAD as Bridge to Transplant in Children : A Single Institution Experience. In: Artificial Organs. 2016 ; Vol. 40, No. 1. pp. 85-89.
@article{ec67e89ac3d34c3f84d4b73a6e97be3e,
title = "Early Outcomes With HeartWare HVAD as Bridge to Transplant in Children: A Single Institution Experience",
abstract = "The HeartWare HVAD has been used as a bridge to cardiac transplantation in the pediatric population. We describe outcomes following HeartWare HVAD implantation at a single center. A retrospective chart review was performed of all HeartWare HVAD implants performed at our institution between May 2013 and March 2015. Eight children between the ages of 9 and 17 years underwent HVAD implantation as a bridge to transplant (N=7 cardiomyopathy, N=1 complex single ventricle). There was one operative death in the complex single ventricle patient. Seven patients (87{\%}) were successfully bridged to transplant. Median time of support was 24.5 days (range, 6-91 days). All transplanted patients are alive and well at a median follow-up of 448 days. Our results demonstrated that mechanical support with HeartWare HVAD is feasible in patients of varying sizes (from older children to adolescents).",
keywords = "Cardiac transplantation, Heart failure, Pediatric, Ventricular assist device",
author = "Giuseppe Ferro and Raghav Murthy and Derek Williams and Sebastian, {Vinod A.} and Forbess, {Joseph M.} and Guleserian, {Kristine J.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1111/aor.12637",
language = "English (US)",
volume = "40",
pages = "85--89",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "1",

}

Early Outcomes With HeartWare HVAD as Bridge to Transplant in Children : A Single Institution Experience. / Ferro, Giuseppe; Murthy, Raghav; Williams, Derek; Sebastian, Vinod A.; Forbess, Joseph M.; Guleserian, Kristine J.

In: Artificial Organs, Vol. 40, No. 1, 01.01.2016, p. 85-89.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Early Outcomes With HeartWare HVAD as Bridge to Transplant in Children

T2 - A Single Institution Experience

AU - Ferro, Giuseppe

AU - Murthy, Raghav

AU - Williams, Derek

AU - Sebastian, Vinod A.

AU - Forbess, Joseph M.

AU - Guleserian, Kristine J.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The HeartWare HVAD has been used as a bridge to cardiac transplantation in the pediatric population. We describe outcomes following HeartWare HVAD implantation at a single center. A retrospective chart review was performed of all HeartWare HVAD implants performed at our institution between May 2013 and March 2015. Eight children between the ages of 9 and 17 years underwent HVAD implantation as a bridge to transplant (N=7 cardiomyopathy, N=1 complex single ventricle). There was one operative death in the complex single ventricle patient. Seven patients (87%) were successfully bridged to transplant. Median time of support was 24.5 days (range, 6-91 days). All transplanted patients are alive and well at a median follow-up of 448 days. Our results demonstrated that mechanical support with HeartWare HVAD is feasible in patients of varying sizes (from older children to adolescents).

AB - The HeartWare HVAD has been used as a bridge to cardiac transplantation in the pediatric population. We describe outcomes following HeartWare HVAD implantation at a single center. A retrospective chart review was performed of all HeartWare HVAD implants performed at our institution between May 2013 and March 2015. Eight children between the ages of 9 and 17 years underwent HVAD implantation as a bridge to transplant (N=7 cardiomyopathy, N=1 complex single ventricle). There was one operative death in the complex single ventricle patient. Seven patients (87%) were successfully bridged to transplant. Median time of support was 24.5 days (range, 6-91 days). All transplanted patients are alive and well at a median follow-up of 448 days. Our results demonstrated that mechanical support with HeartWare HVAD is feasible in patients of varying sizes (from older children to adolescents).

KW - Cardiac transplantation

KW - Heart failure

KW - Pediatric

KW - Ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=84956848501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956848501&partnerID=8YFLogxK

U2 - 10.1111/aor.12637

DO - 10.1111/aor.12637

M3 - Article

VL - 40

SP - 85

EP - 89

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 1

ER -